Curaleaf and The Baldwin Fund Unite for Breast Cancer Research in October

Curaleaf Partners with The Baldwin Fund for Breast Cancer Research

In an inspiring show of commitment to community health and breast cancer awareness, Curaleaf Holdings, Inc., a prominent player in the cannabis market, has announced its collaboration with The Baldwin Fund this October. As part of the Breast Cancer Action Month (BCAM), customers visiting Curaleaf's retail locations will have the opportunity to contribute to a noble cause by participating in the “Round Up for Research” initiative during checkout.

Details of the Initiative

Throughout the month of October, shoppers can opt to round up their purchases, with the surplus directed towards funding critical breast cancer research at Upstate Medical University, located in Syracuse, New York. This year marks six years of Curaleaf's nationwide at-register donation campaign, which significantly benefits The Carol M. Baldwin Breast Cancer Research Fund of Central New York, informally referred to as The Baldwin Fund.

Stephen Baldwin, a member of the Baldwin family and an advocate for the Fund, expressed his enthusiasm for the partnership, stating, "This collaboration not only honors my mother’s mission—‘Together We Will Find a Cure’—but also empowers individuals across America to join the fight against breast cancer in a meaningful way." The Baldwin Fund has successfully raised over $13 million in its two-decade journey, now ambitiously venturing into a campaign aiming for $50 million to achieve National Cancer Institute (NCI) designation for the Upstate Cancer Center.

Impact Beyond Donations

Boris Jordan, the Chairman and CEO of Curaleaf, highlighted the importance of this initiative, emphasizing that BCAM represents a moment for reflection and support for those affected by breast cancer. “Our partnership with The Baldwin Fund invites our customers to honor the journey of survivors and actively participate in supporting groundbreaking research aimed at eradicating this disease,” he stated. While cannabis itself is not a treatment for cancer, many patients have reported benefits from its use, such as pain relief and management of treatment side effects including nausea and anxiety.

The ongoing research into the therapeutic potential of cannabis could provide complementary options for patients dealing with major health challenges. Curaleaf remains dedicated to delivering high-quality cannabis products, ensuring accessibility for individuals navigating their health journeys.

A Nationwide Participation

The charitable effort will take place in the majority of Curaleaf’s dispensaries across the states where they operate, including Arizona, Connecticut, Florida, Illinois, Maine, Maryland, Massachusetts, Nevada, New Jersey, New York, North Dakota, Pennsylvania, and Utah. This strategic nationwide approach amplifies the impact of community contributions, bringing together cannabis consumers to support a cause that resonates deeply with many.

For those interested in additional details on Curaleaf’s offerings, resources for patients, and their full range of products, visit the Curaleaf website at curaleaf.com.

About The Baldwin Fund

Founded by Carol M. Baldwin in 2001, The Baldwin Fund has evolved into a leader in fighting breast cancer and funding research for all cancers. Rooted in the belief that collective efforts can drive significant change, the Fund continues to inspire hope and support for patients and families affected by cancer, working tirelessly to fulfill its mission of finding a cure.

For more insights into the organization's endeavors, visit thebaldwinfund.org.

This partnership exemplifies how businesses can contribute to societal well-being while offering their customers a chance to make a difference. Through actions like the “Round Up for Research,” individuals can transform everyday purchases into lifesaving contributions, showcasing community strength and compassion in combatting breast cancer.